ARVINAS, INC. Current State and Local Tax Expense (Benefit)
ARVINAS, INC. (ARVN) reported Current State and Local Tax Expense (Benefit) of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-24
- ARVINAS, INC. current state and local tax expense (benefit) for the quarter ending 2019-09-30 was $0.00.
- ARVINAS, INC. current state and local tax expense (benefit) for the quarter ending 2019-06-30 was $0.00.
- ARVINAS, INC. current state and local tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
- ARVINAS, INC. current state and local tax expense (benefit) for the quarter ending 2018-09-30 was $0.00.
- ARVINAS, INC. current state and local tax expense (benefit) for fiscal 2025 was $600.00K, a 0.00% change from fiscal 2024.
- ARVINAS, INC. current state and local tax expense (benefit) for fiscal 2024 was $600.00K, a 76.92% decline from fiscal 2023.
- ARVINAS, INC. current state and local tax expense (benefit) for fiscal 2023 was $2.60M, a 79.53% decline from fiscal 2022.
- ARVINAS, INC. current state and local tax expense (benefit) for fiscal 2022 was $12.70M.
| Period end | Current State and Local Tax Expense (Benefit) 3 month | Current State and Local Tax Expense (Benefit) 6 month | Current State and Local Tax Expense (Benefit) 9 month | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $600.00K 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $2.60M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $12.70M 10-K · filed 2025-02-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |